Is minimally elevated alfa feto protein (AFP) in patients with cirrhosis associated with hepatocellular carcinoma (HCC)? single center study based on histology of explanted liver specimens

Shah, Shamita; Nair*, Satheesh
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS105
Academic Journal
An abstract of the article "Is Minimally Elevated Alfa Feto Protein (AFP) in Patients With Cirrhosis Associated With Hepatocellular Carcinoma (HCC)? Single Center Study Based on Histology of Explanted Liver Specimens" by Shamita Shah and Satheesh Nair is presented.


Related Articles

  • FREQUENCY OF HEPATOCELLULAR CARCINOMA IN CIRRHOSIS. Amin, Said; Shabbier, Ghulam; Ul Haq, Anwar; Wazir, Muhammad Noor // Professional Medical Journal;Jan/Feb2012, Vol. 19 Issue 1, p73 

    Objective: To find the frequency of hepatocellular carcinoma in cirrhotic patients of our population. Design: Prospective observational study. Setting: Medical A Unit Hayat Abad Medical Complex Peshawar. Period: 1st January 2010 to 31st July 2011. Material & methods: All patients were screened...

  • Diagnostic Role of Serum Glypican-3 as a Tumor Marker for Hepatocellular Carcinoma. El-Shenawy, Soha Z.; El.Sabawi, Maha M.; Sheble, Nashwa; El-Raof, Mona Abd; Allam, Maha M.; Allah, Samar K. // Nature & Science;4/25/2012, Vol. 10 Issue 4, p32 

    Hepatocellular carcinoma (HCC) is a major health problem. It has been increasing in Egypt with a doubling in the incidence rate in the past 10 years. It represents the most common primary malignant tumor of the liver and is one of the major causes of death among patients with cirrhosis. Current...

  • Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China. Yuanyuan Li; Zheng Zhang; Jianfei Shi; Lei Jin; Lifeng Wang; Dongping Xu; Fu-Sheng Wang // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 1, p1205 

    Aims: Early onset of hepatocellular carcinoma (HCC) (males and females under the age of 40 or 50 years old, respectively) has a significant prevalence and poor prognosis; however, few studies have reported the risk factors and development of HCC in such cases. Methods: In this study, we...

  • A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. Biselli, M; Conti, F; Gramenzi, A; Frigerio, M; Cucchetti, A; Fatti, G; D'Angelo, M; Dall'Agata, M; Giannini, E G; Farinati, F; Ciccarese, F; Andreone, P; Bernardi, M; Trevisani, F // British Journal of Cancer;1/6/2015, Vol. 112 Issue 1, p69 

    Background:Surveillance for hepatocellular carcinoma (HCC) is recommended in patients with cirrhosis. As α-fetoprotein (AFP) is considered a poor surveillance test, we tested the performance of its changes over time.Methods:Eighty patients were diagnosed with HCC (cases) during semiannual...

  • The Postresection Alpha-Fetoprotein in Cirrhotic Patients with Hepatocellular Carcinoma. An Independent Predictor of Outcome. Allard, Marc-Antoine; Sa Cunha, Antonio; Ruiz, Aldrick; Vibert, Eric; Sebagh, Mylène; Castaing, Denis; Adam, René // Journal of Gastrointestinal Surgery;Apr2014, Vol. 18 Issue 4, p701 

    Background: The postresection alpha-fetoprotein (AFP) in cirrhotic patients with hepatocellular carcinoma (HCC) may predict overall survival (OS) and recurrence beyond Milan criteria (MC) among the subgroup of initially transplantable patients. Methods: All patients with cirrhosis resected for...

  • SCREENINGUL PACIENÅ¢ILOR CU CIROZÄ‚ ÃŽN VEDEREA DIAGNOSTICULUI PRECOCE AL CARCINOMULUI HEPATOCELULAR. Tripon, Simona; Grigorescu, Mircea; Chiorean, Erica; Cavaşi, Adriana; Badea, Radu // Clujul Medical;Mar2010, Vol. 83 Issue 1, p133 

    Aims: The goal of the study was to evaluate the efficacy of regular ultrasound and laboratory follow-up for early detection of HCC and to identify parameters correlated to a higher risk of developing HCC and mortality in patients with cirrhosis. Patients and methods: One hundred and two patients...

  • Response to Houlihan et al. Dhanasekaran, Renumathy; Kim, Hyun S // American Journal of Gastroenterology;Nov2013, Vol. 108 Issue 11, p1807 

    A response from the authors of the article "Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis" in 2010 issue is presented.

  • Estimated Short-Term Mortality Following TIPS Insertion for Patients With Hepatic Hydrothorax. Parker, R; Armstrong, M J; Rowe, I A; Houlihan, Diarmaid D // American Journal of Gastroenterology;Nov2013, Vol. 108 Issue 11, p1806 

    A letter to the editor is presented in response to the article "Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis" by R. Dhanasekaran and colleagues in 2010 issue.

  • Bleeding time in patients with hepatic cirrhosis. Blake, J.C.; Sprengers, D.; Grech, P.; McCormick, P.A.; McIntyre, N.; Burroughs, A.K. // BMJ: British Medical Journal (International Edition);7/1/90, Vol. 301 Issue 6742, p12 

    Determines the frequency of an abnormal bleeding time in patients with cirrhosis in Great Britain. Factors affecting primary hemostasis and to the severity of liver disease; Existence of a correlation between the bleeding time and the platelet count; Appropriateness of the measurement of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics